| Literature DB >> 35187169 |
Mir Abdul Qadir1, Nadeem Rashid1, Mohummad Alam Mengal1, Muhammad Sharif Hasni2, Shahab Ud Din Kakar3, Ghulam Mustafa Khan4, Nisar Ahmed Shawani5, Imran Ali2,6, Irfan Shahzad Sheikh1, Nasimullah Khan7.
Abstract
Anemia is associated with poor health outcomes, and the prevalence of anemia is a significant public health indicator for both developed and developing countries. Iron-deficiency anemia (IDA) is the most common type of anemia, which often develops during pregnancy. A cross-sectional study was conducted in the urban areas of Quetta city among the women of reproductive age (15-49 years) to update the status of IDA in the region. The study participants (n = 216) were selected on a random basis, and the samples were further distributed by age. Overall, 75% of females were nonanemic, and among those that were anemic, 2% were severe, 13% were moderately, and 10% were mildly anemic. Among the IDA-affected women, 83% were non-pregnant. Age-wise distribution of IDA revealed no significant difference among different age groups, but numerically higher observations were recorded in the age groups of less than 30 years. The highest number of moderately IDA-affected women (15%) were in the age group 15-19 with the following IDA indicating parameters: hemoglobin 9.64 g/dl, mean corpuscular volume 63.11 fl, mean corpuscular hemoglobin 20.40%, red cell distribution 19.28%. This study will be beneficial for illustrating the requirement and the development of a program to raise extended awareness in the Quetta communities to overcome the negative health effects of IDA on the female population.Entities:
Mesh:
Year: 2022 PMID: 35187169 PMCID: PMC8849966 DOI: 10.1155/2022/6677249
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Overview of the status of IDA in women (15-49 y).
| Anemia | Pregnant (%) | Nonpregnant (%) | Total (%) |
|---|---|---|---|
| Non | 12 | 63 | 75 |
| Mild | 2 | 8 | 10 |
| Moderate | 3 | 10 | 13 |
| Severe | 0 | 2 | 2 |
| Total | 17 | 83 | 100 |
Frequency (%) distribution of IDA-positive women by age.
| Age group (years) | A∗ | B∗ | C∗ | D∗ |
|---|---|---|---|---|
| 15-19 | 14.4 | 38.7 | 20 | 5.6 |
| 20-24 | 13.4 | 27.6 | 13.33 | 3.7 |
| 25-29 | 17.6 | 28.9 | 18.33 | 5.1 |
| 30-34 | 16.7 | 25.0 | 15 | 4.2 |
| 35-39 | 15.7 | 26.5 | 15 | 4.2 |
| 40-44 | 12.0 | 30.8 | 13.33 | 3.7 |
| 45-49 | 10.2 | 13.7 | 5 | 1.4 |
A∗ Frequency on the basis of total observations including all age groups. B∗ IDA-positive frequency on the basis of total observations in the respective age group. C∗ IDA-positive frequency on the basis of total positive observations including all age groups. D∗ IDA-positive frequency on the basis of total observations including all age groups.
Hematology data (mean ± SD) for IDA-positive women/age.
| Age group (years) | Hb (g/dl) | MCV (fl) | MCH | RDW (%) |
|---|---|---|---|---|
| 15-19 | 9.64 ± 1.67 | 63.11 ± 8.54 | 20.40 ± 2.96 | 19.28 ± 2.86 |
| 20-24 | 10.26 ± 1.13 | 69.33 ± 15.17 | 22.66 ± 5.69 | 19.01 ± 5.20 |
| 25-29 | 10.41 ± 1.16 | 69.08 ± 4.46 | 22.69 ± 1.77 | 17.59 ± 2.64 |
| 30-34 | 10.74 ± 1.26 | 67.20 ± 11.28 | 21.63 ± 4.29 | 17.83 ± 3.84 |
| 35-39 | 10.91 ± 0.71 | 75.20 ± 12.46 | 24.41 ± 4.37 | 17.74 ± 4.56 |
| 40-44 | 10.21 ± 1.75 | 73.22 ± 18.50 | 21.60 ± 5.88 | 19.15 ± 4.63 |
| 45-49 | 10.50 ± 0.34 | 71.73 ± 6.87 | 24.13 ± 2.22 | 15.80 ± 2.30 |
| Over all | 10.35 ± 1.30 | 69.53 ± 12.05 | 22.35 ± 4.20 | 18.28 ± 3.84 |
Distribution of the severity of IDA in affected women/age under WHO criteria.
| Age group (years) | Mild | Moderate | Severe | |||
|---|---|---|---|---|---|---|
| A∗ | B∗ | A∗ | B∗ | A∗ | B∗ | |
| 15-19 | 8.7 | 3.3 | 26.5 | 15.0 | 33.3 | 1.7 |
| 20-24 | 13.0 | 5.0 | 14.7 | 8.3 | 0.0 | 0.0 |
| 25-29 | 13.0 | 5.0 | 23.5 | 13.3 | 0.0 | 0.0 |
| 30-34 | 26.1 | 10.0 | 5.9 | 3.3 | 33.3 | 1.7 |
| 35-39 | 21.7 | 8.3 | 11.8 | 6.7 | 0.0 | 0.0 |
| 40-44 | 17.4 | 6.7 | 8.8 | 5.0 | 33.3 | 1.7 |
| 45-49 | 0.0 | 0.0 | 8.8 | 5.0 | 0.0 | 0.0 |
A∗ Percentage on the basis of severity (mild/moderate/severe) of IDA-positive women. B∗ Percentage on the basis of total IDA-positive women.